Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells
- 20 June 2008
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 371 (1), 110-113
- https://doi.org/10.1016/j.bbrc.2008.04.006
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Evaluation of Immunomodulators, Interferons and Known in Vitro SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c MiceAntiviral Chemistry and Chemotherapy, 2006
- Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirinAntiviral Research, 2006
- Antiviral RNAi therapy: emerging approaches for hitting a moving targetGene Therapy, 2005
- Apical Entry and Release of Severe Acute Respiratory Syndrome-Associated Coronavirus in Polarized Calu-3 Lung Epithelial CellsJournal of Virology, 2005
- Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptidesProceedings of the National Academy of Sciences, 2004
- The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitorProceedings of the National Academy of Sciences, 2003
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern ChinaScience, 2003
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003
- Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirusThe Lancet, 2003
- Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trialHepatology, 1997